Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control

PD-1 is a key negative regulator of CD8 + T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechan...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Nature immunology Ročník 25; číslo 10; s. 1871 - 1883
Hlavní autori:	Weiss, Sarah A., Huang, Amy Y., Fung, Megan E., Martinez, Daniela, Chen, Alex C. Y., LaSalle, Thomas J., Miller, Brian C., Scharer, Christopher D., Hegde, Mudra, Nguyen, Thao H., Rowe, Jared H., Osborn, Jossef F., Patterson, Dillon G., Sifnugel, Natalia, Mei-An Nolan, C., Davidson, Richard A., Schwartz, Marc A., Bally, Alexander P. R., Neeld, Dennis K., LaFleur, Martin W., Boss, Jeremy M., Doench, John G., Nicholas Haining, W., Sharpe, Arlene H., Sen, Debattama R.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	New York Nature Publishing Group US 01.10.2024 Nature Publishing Group
Predmet:	631/250/1619/554/1834 631/250/2502/2170 631/250/255/2514 631/337/100/102 Animals Biomedical and Life Sciences Biomedicine CD8 antigen CD8-Positive T-Lymphocytes - immunology Cell activation Chronic infection Clonal deletion Enhancer Elements, Genetic - genetics Epigenesis, Genetic Epigenetics Immunological memory Immunology Infections Infectious Diseases Lymphocyte Activation - immunology Lymphocytes Lymphocytes T Lymphocytic Choriomeningitis - immunology Lymphocytic Choriomeningitis - virology Memory cells Mice Mice, Inbred C57BL Mice, Knockout PD-1 protein Programmed Cell Death 1 Receptor - genetics Programmed Cell Death 1 Receptor - metabolism Viral infections
ISSN:	1529-2908, 1529-2916, 1529-2916
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Abstract	PD-1 is a key negative regulator of CD8 + T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8 + T cells in chronic infection, creating a ‘sweet spot’ of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1 -knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8 + T cell dysfunction while avoiding excess immunopathology. PD-1 is a critical modulator of CD8 + T cell activation and exhaustion. Sen and colleagues show that a cell-state-specific enhancer tunes PD-1 expression exclusively in exhaustion and that deletion of this enhancer improves CD8 + T cell function.
AbstractList	PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8+ T cells in chronic infection, creating a 'sweet spot' of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1-knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8+ T cell dysfunction while avoiding excess immunopathology.PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8+ T cells in chronic infection, creating a 'sweet spot' of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1-knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8+ T cell dysfunction while avoiding excess immunopathology. PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. While PD-1 blockade can improve viral and tumor control, physiologic PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a novel mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8+ T cells in chronic infection, creating a “sweet spot” of intermediate expression where T cell function is optimized compared to wildtype and PD-1 knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8+ T cell dysfunction while avoiding excess immunopathology. PD-1 is a key negative regulator of CD8 T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8 T cells in chronic infection, creating a 'sweet spot' of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1-knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8 T cell dysfunction while avoiding excess immunopathology. PD-1 is a key negative regulator of CD8 + T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8 + T cells in chronic infection, creating a ‘sweet spot’ of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1 -knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8 + T cell dysfunction while avoiding excess immunopathology. PD-1 is a critical modulator of CD8 + T cell activation and exhaustion. Sen and colleagues show that a cell-state-specific enhancer tunes PD-1 expression exclusively in exhaustion and that deletion of this enhancer improves CD8 + T cell function. PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8+ T cells in chronic infection, creating a ‘sweet spot’ of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1-knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8+ T cell dysfunction while avoiding excess immunopathology.PD-1 is a critical modulator of CD8+ T cell activation and exhaustion. Sen and colleagues show that a cell-state-specific enhancer tunes PD-1 expression exclusively in exhaustion and that deletion of this enhancer improves CD8+ T cell function.
Author	Fung, Megan E. Schwartz, Marc A. Doench, John G. Nguyen, Thao H. Scharer, Christopher D. Sharpe, Arlene H. Martinez, Daniela Bally, Alexander P. R. Chen, Alex C. Y. Neeld, Dennis K. LaFleur, Martin W. Osborn, Jossef F. Nicholas Haining, W. Sen, Debattama R. Boss, Jeremy M. Weiss, Sarah A. Rowe, Jared H. Mei-An Nolan, C. Patterson, Dillon G. Huang, Amy Y. Davidson, Richard A. Sifnugel, Natalia LaSalle, Thomas J. Miller, Brian C. Hegde, Mudra
AuthorAffiliation	1 Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA 10 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA 16 Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA 12 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA 5 Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA 2 Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA 7 Department of Medicine, Harvard Medical School, Boston, MA, USA 8 Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, USA 9 Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA 14 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston
AuthorAffiliation_xml	– name: 6 Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA – name: 7 Department of Medicine, Harvard Medical School, Boston, MA, USA – name: 10 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA – name: 16 Department of Pathology, Brigham and Women’s Hospital, Boston, MA, USA – name: 2 Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA – name: 9 Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA – name: 3 Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA – name: 13 Department of Microbiology and Immunology, School of Medicine, Emory University, Atlanta, GA, USA – name: 15 ArsenalBio, San Francisco, California, USA – name: 5 Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA – name: 12 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA – name: 8 Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, Massachusetts 02114, USA – name: 1 Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA – name: 11 Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA – name: 4 Division of Medical Sciences, Harvard Medical School, Boston, MA, USA – name: 14 Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Author_xml	– sequence: 1 givenname: Sarah A. orcidid: 0000-0002-4155-0346 surname: Weiss fullname: Weiss, Sarah A. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Broad Institute of Harvard and Massachusetts Institute of Technology, Division of Medical Sciences, Harvard Medical School – sequence: 2 givenname: Amy Y. orcidid: 0000-0002-6646-6503 surname: Huang fullname: Huang, Amy Y. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Broad Institute of Harvard and Massachusetts Institute of Technology, Division of Population Sciences, Dana-Farber Cancer Institute – sequence: 3 givenname: Megan E. surname: Fung fullname: Fung, Megan E. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School – sequence: 4 givenname: Daniela surname: Martinez fullname: Martinez, Daniela organization: Broad Institute of Harvard and Massachusetts Institute of Technology, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital – sequence: 5 givenname: Alex C. Y. orcidid: 0000-0002-8358-5408 surname: Chen fullname: Chen, Alex C. Y. organization: Broad Institute of Harvard and Massachusetts Institute of Technology, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital – sequence: 6 givenname: Thomas J. surname: LaSalle fullname: LaSalle, Thomas J. organization: Broad Institute of Harvard and Massachusetts Institute of Technology, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital – sequence: 7 givenname: Brian C. surname: Miller fullname: Miller, Brian C. organization: Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Department of Genetics, University of North Carolina at Chapel Hill, Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill – sequence: 8 givenname: Christopher D. orcidid: 0000-0001-7716-8504 surname: Scharer fullname: Scharer, Christopher D. organization: Department of Microbiology and Immunology, School of Medicine, Emory University – sequence: 9 givenname: Mudra surname: Hegde fullname: Hegde, Mudra organization: Broad Institute of Harvard and Massachusetts Institute of Technology – sequence: 10 givenname: Thao H. orcidid: 0000-0002-2767-0528 surname: Nguyen fullname: Nguyen, Thao H. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School – sequence: 11 givenname: Jared H. surname: Rowe fullname: Rowe, Jared H. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Department of Pediatric Oncology, Dana-Farber Cancer Institute – sequence: 12 givenname: Jossef F. surname: Osborn fullname: Osborn, Jossef F. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School – sequence: 13 givenname: Dillon G. surname: Patterson fullname: Patterson, Dillon G. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School – sequence: 14 givenname: Natalia surname: Sifnugel fullname: Sifnugel, Natalia organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School – sequence: 15 givenname: C. orcidid: 0000-0002-8109-7339 surname: Mei-An Nolan fullname: Mei-An Nolan, C. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School – sequence: 16 givenname: Richard A. surname: Davidson fullname: Davidson, Richard A. organization: Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital – sequence: 17 givenname: Marc A. orcidid: 0000-0003-3869-0150 surname: Schwartz fullname: Schwartz, Marc A. organization: Broad Institute of Harvard and Massachusetts Institute of Technology, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital – sequence: 18 givenname: Alexander P. R. surname: Bally fullname: Bally, Alexander P. R. organization: Department of Microbiology and Immunology, School of Medicine, Emory University – sequence: 19 givenname: Dennis K. surname: Neeld fullname: Neeld, Dennis K. organization: Department of Microbiology and Immunology, School of Medicine, Emory University – sequence: 20 givenname: Martin W. orcidid: 0000-0002-5017-774X surname: LaFleur fullname: LaFleur, Martin W. organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School – sequence: 21 givenname: Jeremy M. orcidid: 0000-0002-2432-1840 surname: Boss fullname: Boss, Jeremy M. organization: Department of Microbiology and Immunology, School of Medicine, Emory University – sequence: 22 givenname: John G. orcidid: 0000-0002-3707-9889 surname: Doench fullname: Doench, John G. organization: Broad Institute of Harvard and Massachusetts Institute of Technology – sequence: 23 givenname: W. orcidid: 0000-0001-7871-3762 surname: Nicholas Haining fullname: Nicholas Haining, W. organization: Broad Institute of Harvard and Massachusetts Institute of Technology, Department of Pediatric Oncology, Dana-Farber Cancer Institute, ArsenalBio – sequence: 24 givenname: Arlene H. orcidid: 0000-0002-9736-2109 surname: Sharpe fullname: Sharpe, Arlene H. email: arlene_sharpe@hms.harvard.edu organization: Department of Immunology, Blavatnik Institute, Harvard Medical School, Gene Lay Institute of Immunology and Inflammation, Brigham and Women’s Hospital, Massachusetts General Hospital and Harvard Medical School, Broad Institute of Harvard and Massachusetts Institute of Technology, Department of Pathology, Brigham and Women’s Hospital – sequence: 25 givenname: Debattama R. orcidid: 0000-0002-0947-8284 surname: Sen fullname: Sen, Debattama R. email: dsen@mgh.harvard.edu organization: Broad Institute of Harvard and Massachusetts Institute of Technology, Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Department of Medicine, Harvard Medical School, Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/39289557$$D View this record in MEDLINE/PubMed
BookMark	eNp9kTtvFDEUhS2UiDzgD1AgSzQ0A77jx4wrhEICkSKFIhRUltePjaNZe7BnVvDv42GTEFJELmzZ3z0-954jtBdTdAi9AfIBCO0_FgZckoa0rCEgBTT0BToE3sqmlSD2Hs6kP0BHpdwQAqwT7CU6oLLtJefdIfp5Ooa1i24KBk9zDHGNk8ffvzSA3e8xu1JCijhsxpy2rtS7az2XyVl8hY0bBuznaKYF0dHibch6wCbFKafhFdr3eiju9d1-jH6cnV6dfGsuLr-en3y-aAyjMDWGaN8RDrSula3-OGWG9tq3FqSkAnjnjQAjBPUWLPOdtR0TK8O4cGxF6TH6tNMd59XGWePq73pQYw4bnf-opIP6_yWGa7VOWwV1PL3ou6rw_k4hp1-zK5PahLJ0p6NLc1EUiGBcdi2v6Lsn6E2ac6z9VQoI54KzhXr72NKDl_uxV6DfASanUrLzyoRJL3OsDsOggKglYbVLWNWE1d-E1dJu-6T0Xv3ZIrorKhWOa5f_2X6m6haTxrhK
CitedBy_id	crossref_primary_10_1016_j_actbio_2025_08_014 crossref_primary_10_1016_j_omton_2025_200989 crossref_primary_10_1016_j_clim_2025_110486 crossref_primary_10_1084_jem_20241433 crossref_primary_10_1097_TP_0000000000005399 crossref_primary_10_1016_j_nantod_2025_102842 crossref_primary_10_3389_fimmu_2025_1630940 crossref_primary_10_1038_s41467_025_60448_3 crossref_primary_10_3389_fimmu_2025_1563894 crossref_primary_10_1038_s41380_025_02969_3 crossref_primary_10_1016_j_carbon_2025_120533 crossref_primary_10_1016_j_xcrm_2025_102353 crossref_primary_10_1136_jitc_2025_011944 crossref_primary_10_3390_ijms26167806
Cites_doi	10.1038/ng.3646 10.1016/j.immuni.2019.10.009 10.1056/NEJMoa1200690 10.1056/NEJMoa1603702 10.1128/JVI.77.8.4911-4927.2003 10.1016/j.immuni.2019.09.013 10.1016/j.immuni.2019.11.002 10.1093/nar/gkab1113 10.1038/s41586-019-0985-x 10.1016/j.cels.2015.12.004 10.1073/pnas.1009731107 10.1038/s41586-019-1325-x 10.3389/fmolb.2021.745286 10.1073/pnas.1512503112 10.1016/j.immuni.2007.11.006 10.1128/jvi.68.12.8056-8063.1994 10.1056/NEJMoa1510665 10.1073/pnas.192461099 10.1073/pnas.0506580102 10.1016/j.xpro.2023.102125 10.1038/s41586-019-1326-9 10.1038/s41423-021-00749-x 10.1038/s41590-022-01337-5 10.1038/nature04444 10.1016/j.ccell.2015.06.012 10.1038/nature19330 10.1126/scitranslmed.aba6006 10.1126/science.aaf2807 10.1126/science.aah4573 10.1016/j.cell.2018.12.036 10.1016/j.immuni.2020.04.014 10.1038/s41467-020-18035-1 10.1038/s41590-022-01338-4 10.1056/NEJMoa1606774 10.1084/jem.188.12.2205 10.1038/s41586-019-1324-y 10.1038/s41590-019-0312-6 10.1016/j.immuni.2012.08.021 10.1056/NEJMoa1602252 10.1084/jem.20142237 10.1126/science.aae0491 10.1038/s41590-019-0480-4 10.1016/j.celrep.2020.107827 10.1084/jem.20121015 10.1126/science.aba7365 10.4049/jimmunol.1701470
ContentType	Journal Article
Copyright	The Author(s), under exclusive licence to Springer Nature America, Inc. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
Copyright_xml	– notice: The Author(s), under exclusive licence to Springer Nature America, Inc. 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. – notice: 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
DBID	AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QP 7QR 7T5 7TK 7TM 7U9 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FH 8FI 8FJ 8FK ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. LK8 M0S M1P M7N M7P P64 PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI RC3 7X8 5PM
DOI	10.1038/s41590-024-01961-3
DatabaseName	CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Chemoreception Abstracts Immunology Abstracts Neurosciences Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials - QC Biological Science Collection ProQuest Central Natural Science Collection ProQuest One Community College ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni) Medical Database Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Biotechnology and BioEngineering Abstracts ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles)
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Central Student Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest One Applied & Life Sciences ProQuest One Sustainability ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Algology Mycology and Protozoology Abstracts (Microbiology C) Health & Medical Research Collection Biological Science Collection AIDS and Cancer Research Abstracts Chemoreception Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts Engineering Research Database ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic
DatabaseTitleList	MEDLINE - Academic MEDLINE ProQuest Central Student
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: AUTh Library subscriptions: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Medicine Biology
EISSN	1529-2916
EndPage	1883
ExternalDocumentID	PMC11528687 39289557 10_1038_s41590_024_01961_3
Genre	Journal Article
GrantInformation_xml	– fundername: U.S. Department of Health & Human Services \| NIH \| National Institute of Allergy and Infectious Diseases (NIAID) grantid: DP2 AI176139; U19 AI082630; P01 AI052699; R01 AI113021; R01 AI113021; R01 AI113021; R01 AI113021 funderid: https://doi.org/10.13039/100000060 – fundername: U.S. Department of Health & Human Services \| NIH \| National Cancer Institute (NCI) grantid: T32 CA207021; T32 CA921643; K08 CA248960 funderid: https://doi.org/10.13039/100000054 – fundername: Melanoma Research Alliance (MRA) funderid: https://doi.org/10.13039/100005190 – fundername: U.S. Department of Health & Human Services \| NIH \| National Institute of General Medical Sciences (NIGMS) grantid: T32 GM007753; T32 GM144273; T32 GM144273 funderid: https://doi.org/10.13039/100000057 – fundername: V Foundation for Cancer Research (V Foundation) funderid: https://doi.org/10.13039/100001368 – fundername: NIAID NIH HHS grantid: DP2 AI176139 – fundername: U.S. Department of Health & Human Services \| NIH \| National Institute of Allergy and Infectious Diseases (NIAID) grantid: P01 AI052699 – fundername: NIAID NIH HHS grantid: U19 AI082630 – fundername: NIAID NIH HHS grantid: R01 AI113021 – fundername: NCI NIH HHS grantid: T32 CA009172 – fundername: NCI NIH HHS grantid: K08 CA248960 – fundername: U.S. Department of Health & Human Services \| NIH \| National Cancer Institute (NCI) grantid: T32 CA921643 – fundername: NIAID NIH HHS grantid: P01 AI056299 – fundername: NIGMS NIH HHS grantid: T32 GM007753 – fundername: NCI NIH HHS grantid: T32 CA009216
GroupedDBID	--- .55 0R~ 123 29M 2FS 36B 39C 3V. 4.4 53G 5BI 5RE 70F 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8R4 8R5 AAEEF AAHBH AARCD AAYZH AAZLF ABAWZ ABDBF ABJNI ABLJU ABNNU ABOCM ABUWG ACBWK ACGFS ACIWK ACPRK ACRPL ACUHS ADBBV ADNMO AENEX AEUYN AFBBN AFKRA AFRAH AFSHS AGAYW AGGDT AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ AIYXT ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS ARMCB ASPBG AVWKF AXYYD AZFZN BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 EAD EAP EAS EBS EE. EJD EMB EMK EMOBN ESX EXGXG F5P FEDTE FQGFK FSGXE FYUFA HCIFZ HMCUK HVGLF HZ~ IAO IHR INH INR ISR ITC L-9 LK8 M1P M7P N9A NNMJJ O9- ODYON P2P PQQKQ PROAC PSQYO Q2X RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG TUS UKHRP WH7 X7M Y6R ZXP AAYXX ABFSG ACSTC AEZWR AFANA AFFHD AFHIU AGSTI AHWEU AIXLP ALPWD ATHPR CITATION NFIDA PHGZM PHGZT PJZUB PPXIY PQGLB AGQPQ CGR CUY CVF ECM EIF NPM 7QP 7QR 7T5 7TK 7TM 7U9 7XB 8FD 8FK AZQEC DWQXO FR3 GNUQQ H94 K9. M7N P64 PKEHL PQEST PQUKI RC3 7X8 5PM
ID	FETCH-LOGICAL-c431t-c0af70513131bd476534c38af2d19936157fc61c663fd1d4f7dd746bc456e4b33
IEDL.DBID	M7P
ISICitedReferencesCount	16
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=001314855400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1529-2908 1529-2916
IngestDate	Tue Nov 04 02:06:17 EST 2025 Sun Nov 09 11:35:19 EST 2025 Tue Oct 07 05:28:59 EDT 2025 Tue Jul 22 01:42:05 EDT 2025 Sat Nov 29 02:12:28 EST 2025 Tue Nov 18 21:55:45 EST 2025 Fri Feb 21 02:39:01 EST 2025
IsPeerReviewed	true
IsScholarly	true
Issue	10
Language	English
License	2024. The Author(s), under exclusive licence to Springer Nature America, Inc.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c431t-c0af70513131bd476534c38af2d19936157fc61c663fd1d4f7dd746bc456e4b33
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 S.A.W., D.R.S., W.N.H. and A.H.S. conceived the study and designed the experiments. S.A.W., A.Y.H., M.E.F., D.M., A.C.Y.C., T.J.L., B.C.M., M.H., T.H.N., J.H.R., N.S., C.M.N., D.G.P., J.F.O., and R.A.D. performed experiments and/or data analysis. A.P.R.B., D.K.N, C.D.S., and J.M.B. provided ATAC-seq data. S.A.W., D.R.S. and A.H.S. wrote the manuscript. M.A.S., M.W.L., J.G.D., and W.N.H. contributed key discussions. All authors reviewed and edited the manuscript. Author Contribution Statement
ORCID	0000-0002-6646-6503 0000-0001-7716-8504 0000-0002-3707-9889 0000-0002-9736-2109 0000-0002-4155-0346 0000-0002-8109-7339 0000-0002-8358-5408 0000-0001-7871-3762 0000-0002-2432-1840 0000-0002-5017-774X 0000-0002-0947-8284 0000-0003-3869-0150 0000-0002-2767-0528
PMID	39289557
PQID	3110556545
PQPubID	45782
PageCount	13
ParticipantIDs	pubmedcentral_primary_oai_pubmedcentral_nih_gov_11528687 proquest_miscellaneous_3106459725 proquest_journals_3110556545 pubmed_primary_39289557 crossref_citationtrail_10_1038_s41590_024_01961_3 crossref_primary_10_1038_s41590_024_01961_3 springer_journals_10_1038_s41590_024_01961_3
PublicationCentury	2000
PublicationDate	2024-10-01
PublicationDateYYYYMMDD	2024-10-01
PublicationDate_xml	– month: 10 year: 2024 text: 2024-10-01 day: 01
PublicationDecade	2020
PublicationPlace	New York
PublicationPlace_xml	– name: New York – name: United States
PublicationTitle	Nature immunology
PublicationTitleAbbrev	Nat Immunol
PublicationTitleAlternate	Nat Immunol
PublicationYear	2024
Publisher	Nature Publishing Group US Nature Publishing Group
Publisher_xml	– name: Nature Publishing Group US – name: Nature Publishing Group
References	Odorizzi (CR23) 2015; 212 Scott (CR8) 2019; 571 Wang (CR39) 2021; 18 Barber (CR3) 2006; 439 Iwai (CR14) 2002; 99 Bentsen (CR31) 2020; 11 Doering (CR34) 2012; 37 Hudson (CR10) 2019; 51 Kelderman, Schumacher, Kvistborg (CR20) 2015; 28 Jin (CR4) 2010; 107 Nghiem (CR18) 2016; 374 Guo (CR43) 2018; 200 Reck (CR16) 2016; 375 Pauken (CR26) 2016; 354 Matloubian, Concepcion, Ahmed (CR28) 1994; 68 Miller (CR25) 2019; 20 Castro-Mondragon (CR32) 2022; 50 Topalian (CR15) 2012; 366 Beltra (CR30) 2020; 52 Chen (CR29) 2019; 51 Wherry (CR5) 2007; 27 Ferris (CR17) 2016; 375 Motzer (CR19) 2015; 373 Zajac (CR1) 1998; 188 Wherry (CR2) 2003; 77 Alfei (CR6) 2019; 571 Sen (CR24) 2016; 354 Giles (CR12) 2022; 23 Daniel (CR13) 2022; 23 Schumann (CR40) 2015; 112 Im (CR9) 2016; 537 Kalia (CR22) 2021; 13 Frebel (CR37) 2012; 209 Khan (CR7) 2019; 571 Yoshida (CR27) 2019; 176 LaFleur (CR42) 2019; 20 Zander (CR11) 2019; 51 Stadtmauer (CR38) 2020; 367 Corces (CR44) 2016; 48 Chen (CR33) 2019; 567 Kalinin (CR41) 2021; 8 Gonye (CR46) 2023; 4 Villani (CR45) 2017; 356 Liberzon (CR36) 2015; 1 Pauken (CR21) 2020; 31 Subramanian (CR35) 2005; 102 Z Wang (1961_CR39) 2021; 18 KE Pauken (1961_CR21) 2020; 31 DR Sen (1961_CR24) 2016; 354 JA Castro-Mondragon (1961_CR32) 2022; 50 H-T Jin (1961_CR4) 2010; 107 S Kelderman (1961_CR20) 2015; 28 SJ Im (1961_CR9) 2016; 537 K Schumann (1961_CR40) 2015; 112 RJ Motzer (1961_CR19) 2015; 373 A Liberzon (1961_CR36) 2015; 1 AC Villani (1961_CR45) 2017; 356 TA Doering (1961_CR34) 2012; 37 DL Barber (1961_CR3) 2006; 439 PM Odorizzi (1961_CR23) 2015; 212 BC Miller (1961_CR25) 2019; 20 V Kalia (1961_CR22) 2021; 13 J Chen (1961_CR33) 2019; 567 M Reck (1961_CR16) 2016; 375 R Zander (1961_CR11) 2019; 51 F Alfei (1961_CR6) 2019; 571 AJ Zajac (1961_CR1) 1998; 188 O Khan (1961_CR7) 2019; 571 B Daniel (1961_CR13) 2022; 23 RL Ferris (1961_CR17) 2016; 375 WH Hudson (1961_CR10) 2019; 51 RS Kalinin (1961_CR41) 2021; 8 A Subramanian (1961_CR35) 2005; 102 MW LaFleur (1961_CR42) 2019; 20 EJ Wherry (1961_CR5) 2007; 27 JR Giles (1961_CR12) 2022; 23 Z Chen (1961_CR29) 2019; 51 AC Scott (1961_CR8) 2019; 571 PT Nghiem (1961_CR18) 2016; 374 EA Stadtmauer (1961_CR38) 2020; 367 ALK Gonye (1961_CR46) 2023; 4 J-C Beltra (1961_CR30) 2020; 52 KE Pauken (1961_CR26) 2016; 354 M Guo (1961_CR43) 2018; 200 M Bentsen (1961_CR31) 2020; 11 SL Topalian (1961_CR15) 2012; 366 H Frebel (1961_CR37) 2012; 209 Y Iwai (1961_CR14) 2002; 99 H Yoshida (1961_CR27) 2019; 176 E Wherry (1961_CR2) 2003; 77 M Matloubian (1961_CR28) 1994; 68 MR Corces (1961_CR44) 2016; 48
References_xml	– volume: 48 start-page: 1193 year: 2016 end-page: 1203 ident: CR44 article-title: Lineage-specific and single-cell chromatin accessibility charts human hematopoiesis and leukemia evolution publication-title: Nat. Genet. doi: 10.1038/ng.3646 – volume: 51 start-page: 1028 year: 2019 end-page: 1042 ident: CR11 article-title: CD4 T cell help is required for the formation of a cytolytic CD8 T cell subset that protects against chronic infection and cancer publication-title: Immunity doi: 10.1016/j.immuni.2019.10.009 – volume: 366 start-page: 2443 year: 2012 end-page: 2454 ident: CR15 article-title: Safety, activity, and immune correlates of anti–PD-1 antibody in cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1200690 – volume: 374 start-page: 2542 year: 2016 end-page: 2552 ident: CR18 article-title: PD-1 blockade with pembrolizumab in advanced Merkel-cell carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1603702 – volume: 77 start-page: 4911 year: 2003 end-page: 4927 ident: CR2 article-title: Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment publication-title: J. Virol. doi: 10.1128/JVI.77.8.4911-4927.2003 – volume: 51 start-page: 840 year: 2019 end-page: 855 ident: CR29 article-title: TCF-1-centered transcriptional network drives an effector versus exhausted CD8 T cell-fate decision publication-title: Immunity doi: 10.1016/j.immuni.2019.09.013 – volume: 51 start-page: 1043 year: 2019 end-page: 1058 ident: CR10 article-title: Proliferating transitory T cells with an effector-like transcriptional signature emerge from PD-1 stem-like CD8 T cells during chronic infection publication-title: Immunity doi: 10.1016/j.immuni.2019.11.002 – volume: 50 start-page: D165 year: 2022 end-page: D173 ident: CR32 article-title: JASPAR 2022: the 9th release of the open-access database of transcription factor binding profiles publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkab1113 – volume: 567 start-page: 530 year: 2019 end-page: 534 ident: CR33 article-title: NR4A transcription factors limit CAR T cell function in solid tumours publication-title: Nature doi: 10.1038/s41586-019-0985-x – volume: 1 start-page: 417 year: 2015 end-page: 425 ident: CR36 article-title: The Molecular Signatures Database (MSigDB) hallmark gene set collection publication-title: Cell Syst. doi: 10.1016/j.cels.2015.12.004 – volume: 107 start-page: 14733 year: 2010 end-page: 14738 ident: CR4 article-title: Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1009731107 – volume: 571 start-page: 211 year: 2019 end-page: 218 ident: CR7 article-title: TOX transcriptionally and epigenetically programs CD8 T cell exhaustion publication-title: Nature doi: 10.1038/s41586-019-1325-x – volume: 8 start-page: 745286 year: 2021 ident: CR41 article-title: Engineered removal of PD-1 from the surface of CD19 CAR-T cells results in increased activation and diminished survival publication-title: Front. Mol. Biosci. doi: 10.3389/fmolb.2021.745286 – volume: 112 start-page: 10437 year: 2015 end-page: 10442 ident: CR40 article-title: Generation of knock-in primary human T cells using Cas9 ribonucleoproteins publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1512503112 – volume: 27 start-page: 824 year: 2007 ident: CR5 article-title: Molecular signature of CD8 T cell exhaustion during chronic viral infection publication-title: Immunity doi: 10.1016/j.immuni.2007.11.006 – volume: 68 start-page: 8056 year: 1994 end-page: 8063 ident: CR28 article-title: CD4 T cells are required to sustain CD8 cytotoxic T-cell responses during chronic viral infection publication-title: J. Virol. doi: 10.1128/jvi.68.12.8056-8063.1994 – volume: 373 start-page: 1803 year: 2015 end-page: 1813 ident: CR19 article-title: Nivolumab versus everolimus in advanced renal-cell carcinoma publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1510665 – volume: 99 start-page: 12293 year: 2002 end-page: 12297 ident: CR14 article-title: Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.192461099 – volume: 102 start-page: 15545 year: 2005 end-page: 15550 ident: CR35 article-title: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0506580102 – volume: 4 start-page: 102125 year: 2023 ident: CR46 article-title: Protocol for bulk RNA sequencing of enriched human neutrophils from whole blood and estimation of sample purity publication-title: STAR Protoc. doi: 10.1016/j.xpro.2023.102125 – volume: 571 start-page: 265 year: 2019 end-page: 269 ident: CR6 article-title: TOX reinforces the phenotype and longevity of exhausted T cells in chronic viral infection publication-title: Nature doi: 10.1038/s41586-019-1326-9 – volume: 18 start-page: 2188 year: 2021 end-page: 2198 ident: CR39 article-title: Phase I study of CAR-T cells with PD-1 and TCR disruption in mesothelin-positive solid tumors publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-021-00749-x – volume: 23 start-page: 1614 year: 2022 end-page: 1627 ident: CR13 article-title: Divergent clonal differentiation trajectories of T cell exhaustion publication-title: Nat. Immunol. doi: 10.1038/s41590-022-01337-5 – volume: 439 start-page: 682 year: 2006 end-page: 687 ident: CR3 article-title: Restoring function in exhausted CD8 T cells during chronic viral infection publication-title: Nature doi: 10.1038/nature04444 – volume: 28 start-page: 11 year: 2015 end-page: 13 ident: CR20 article-title: Mismatch repair-deficient cancers are targets for anti-PD-1 therapy publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.06.012 – volume: 537 start-page: 417 year: 2016 end-page: 421 ident: CR9 article-title: Defining CD8 T cells that provide the proliferative burst after PD-1 therapy publication-title: Nature doi: 10.1038/nature19330 – volume: 13 start-page: eaba6006 year: 2021 ident: CR22 article-title: Metabolic regulation by PD-1 signaling promotes long-lived quiescent CD8 T cell memory in mice publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aba6006 – volume: 354 start-page: 1160 year: 2016 end-page: 1165 ident: CR26 article-title: Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade publication-title: Science doi: 10.1126/science.aaf2807 – volume: 356 start-page: eaah4573 year: 2017 ident: CR45 article-title: Single-cell RNA-seq reveals new types of human blood dendritic cells, monocytes, and progenitors publication-title: Science doi: 10.1126/science.aah4573 – volume: 176 start-page: 897 year: 2019 end-page: 912 ident: CR27 article-title: The -regulatory atlas of the mouse immune system publication-title: Cell doi: 10.1016/j.cell.2018.12.036 – volume: 52 start-page: 825 year: 2020 end-page: 841 ident: CR30 article-title: Developmental relationships of four exhausted CD8 T cell subsets reveals underlying transcriptional and epigenetic landscape control mechanisms publication-title: Immunity doi: 10.1016/j.immuni.2020.04.014 – volume: 11 year: 2020 ident: CR31 article-title: ATAC-seq footprinting unravels kinetics of transcription factor binding during zygotic genome activation publication-title: Nat. Commun. doi: 10.1038/s41467-020-18035-1 – volume: 23 start-page: 1600 year: 2022 end-page: 1613 ident: CR12 article-title: Shared and distinct biological circuits in effector, memory and exhausted CD8 T cells revealed by temporal single-cell transcriptomics and epigenetics publication-title: Nat. Immunol. doi: 10.1038/s41590-022-01338-4 – volume: 375 start-page: 1823 year: 2016 end-page: 1833 ident: CR16 article-title: Pembrolizumab versus chemotherapy for PD-L1-positive non-small-cell lung cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1606774 – volume: 188 start-page: 2205 year: 1998 end-page: 2213 ident: CR1 article-title: Viral immune evasion due to persistence of activated T cells without effector function publication-title: J. Exp. Med. doi: 10.1084/jem.188.12.2205 – volume: 571 start-page: 270 year: 2019 end-page: 274 ident: CR8 article-title: TOX is a critical regulator of tumour-specific T cell differentiation publication-title: Nature doi: 10.1038/s41586-019-1324-y – volume: 20 start-page: 326 year: 2019 end-page: 336 ident: CR25 article-title: Subsets of exhausted CD8 T cells differentially mediate tumor control and respond to checkpoint blockade publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0312-6 – volume: 37 start-page: 1130 year: 2012 end-page: 1144 ident: CR34 article-title: Network analysis reveals centrally connected genes and pathways involved in CD8 T cell exhaustion versus memory publication-title: Immunity doi: 10.1016/j.immuni.2012.08.021 – volume: 375 start-page: 1856 year: 2016 end-page: 1867 ident: CR17 article-title: Nivolumab for recurrent squamous-cell carcinoma of the head and neck publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1602252 – volume: 212 start-page: 1125 year: 2015 end-page: 1137 ident: CR23 article-title: Genetic absence of PD-1 promotes accumulation of terminally differentiated exhausted CD8 T cells publication-title: J. Exp. Med. doi: 10.1084/jem.20142237 – volume: 354 start-page: 1165 year: 2016 end-page: 1169 ident: CR24 article-title: The epigenetic landscape of T cell exhaustion publication-title: Science doi: 10.1126/science.aae0491 – volume: 20 start-page: 1335 year: 2019 end-page: 1347 ident: CR42 article-title: PTPN2 regulates the generation of exhausted CD8 T cell subpopulations and restrains tumor immunity publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0480-4 – volume: 31 year: 2020 ident: CR21 article-title: The PD-1 pathway regulates development and function of memory CD8 T cells following respiratory viral infection publication-title: Cell Rep. doi: 10.1016/j.celrep.2020.107827 – volume: 209 start-page: 2485 year: 2012 end-page: 2499 ident: CR37 article-title: Programmed death 1 protects from fatal circulatory failure during systemic virus infection of mice publication-title: J. Exp. Med. doi: 10.1084/jem.20121015 – volume: 367 start-page: eaba7365 year: 2020 ident: CR38 article-title: CRISPR-engineered T cells in patients with refractory cancer publication-title: Science doi: 10.1126/science.aba7365 – volume: 200 start-page: 1039 year: 2018 end-page: 1052 ident: CR43 article-title: EZH2 represses the B cell transcriptional program and regulates antibody-secreting cell metabolism and antibody production publication-title: J. Immunol. doi: 10.4049/jimmunol.1701470 – volume: 356 start-page: eaah4573 year: 2017 ident: 1961_CR45 publication-title: Science doi: 10.1126/science.aah4573 – volume: 20 start-page: 326 year: 2019 ident: 1961_CR25 publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0312-6 – volume: 188 start-page: 2205 year: 1998 ident: 1961_CR1 publication-title: J. Exp. Med. doi: 10.1084/jem.188.12.2205 – volume: 27 start-page: 824 year: 2007 ident: 1961_CR5 publication-title: Immunity doi: 10.1016/j.immuni.2007.11.006 – volume: 367 start-page: eaba7365 year: 2020 ident: 1961_CR38 publication-title: Science doi: 10.1126/science.aba7365 – volume: 209 start-page: 2485 year: 2012 ident: 1961_CR37 publication-title: J. Exp. Med. doi: 10.1084/jem.20121015 – volume: 571 start-page: 265 year: 2019 ident: 1961_CR6 publication-title: Nature doi: 10.1038/s41586-019-1326-9 – volume: 567 start-page: 530 year: 2019 ident: 1961_CR33 publication-title: Nature doi: 10.1038/s41586-019-0985-x – volume: 439 start-page: 682 year: 2006 ident: 1961_CR3 publication-title: Nature doi: 10.1038/nature04444 – volume: 354 start-page: 1160 year: 2016 ident: 1961_CR26 publication-title: Science doi: 10.1126/science.aaf2807 – volume: 23 start-page: 1600 year: 2022 ident: 1961_CR12 publication-title: Nat. Immunol. doi: 10.1038/s41590-022-01338-4 – volume: 77 start-page: 4911 year: 2003 ident: 1961_CR2 publication-title: J. Virol. doi: 10.1128/JVI.77.8.4911-4927.2003 – volume: 1 start-page: 417 year: 2015 ident: 1961_CR36 publication-title: Cell Syst. doi: 10.1016/j.cels.2015.12.004 – volume: 354 start-page: 1165 year: 2016 ident: 1961_CR24 publication-title: Science doi: 10.1126/science.aae0491 – volume: 176 start-page: 897 year: 2019 ident: 1961_CR27 publication-title: Cell doi: 10.1016/j.cell.2018.12.036 – volume: 18 start-page: 2188 year: 2021 ident: 1961_CR39 publication-title: Cell. Mol. Immunol. doi: 10.1038/s41423-021-00749-x – volume: 374 start-page: 2542 year: 2016 ident: 1961_CR18 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1603702 – volume: 28 start-page: 11 year: 2015 ident: 1961_CR20 publication-title: Cancer Cell doi: 10.1016/j.ccell.2015.06.012 – volume: 375 start-page: 1823 year: 2016 ident: 1961_CR16 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1606774 – volume: 375 start-page: 1856 year: 2016 ident: 1961_CR17 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1602252 – volume: 571 start-page: 211 year: 2019 ident: 1961_CR7 publication-title: Nature doi: 10.1038/s41586-019-1325-x – volume: 51 start-page: 1043 year: 2019 ident: 1961_CR10 publication-title: Immunity doi: 10.1016/j.immuni.2019.11.002 – volume: 31 year: 2020 ident: 1961_CR21 publication-title: Cell Rep. doi: 10.1016/j.celrep.2020.107827 – volume: 112 start-page: 10437 year: 2015 ident: 1961_CR40 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1512503112 – volume: 68 start-page: 8056 year: 1994 ident: 1961_CR28 publication-title: J. Virol. doi: 10.1128/jvi.68.12.8056-8063.1994 – volume: 48 start-page: 1193 year: 2016 ident: 1961_CR44 publication-title: Nat. Genet. doi: 10.1038/ng.3646 – volume: 107 start-page: 14733 year: 2010 ident: 1961_CR4 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1009731107 – volume: 373 start-page: 1803 year: 2015 ident: 1961_CR19 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1510665 – volume: 51 start-page: 1028 year: 2019 ident: 1961_CR11 publication-title: Immunity doi: 10.1016/j.immuni.2019.10.009 – volume: 13 start-page: eaba6006 year: 2021 ident: 1961_CR22 publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.aba6006 – volume: 200 start-page: 1039 year: 2018 ident: 1961_CR43 publication-title: J. Immunol. doi: 10.4049/jimmunol.1701470 – volume: 99 start-page: 12293 year: 2002 ident: 1961_CR14 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.192461099 – volume: 366 start-page: 2443 year: 2012 ident: 1961_CR15 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1200690 – volume: 4 start-page: 102125 year: 2023 ident: 1961_CR46 publication-title: STAR Protoc. doi: 10.1016/j.xpro.2023.102125 – volume: 8 start-page: 745286 year: 2021 ident: 1961_CR41 publication-title: Front. Mol. Biosci. doi: 10.3389/fmolb.2021.745286 – volume: 537 start-page: 417 year: 2016 ident: 1961_CR9 publication-title: Nature doi: 10.1038/nature19330 – volume: 212 start-page: 1125 year: 2015 ident: 1961_CR23 publication-title: J. Exp. Med. doi: 10.1084/jem.20142237 – volume: 11 year: 2020 ident: 1961_CR31 publication-title: Nat. Commun. doi: 10.1038/s41467-020-18035-1 – volume: 23 start-page: 1614 year: 2022 ident: 1961_CR13 publication-title: Nat. Immunol. doi: 10.1038/s41590-022-01337-5 – volume: 37 start-page: 1130 year: 2012 ident: 1961_CR34 publication-title: Immunity doi: 10.1016/j.immuni.2012.08.021 – volume: 102 start-page: 15545 year: 2005 ident: 1961_CR35 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0506580102 – volume: 52 start-page: 825 year: 2020 ident: 1961_CR30 publication-title: Immunity doi: 10.1016/j.immuni.2020.04.014 – volume: 50 start-page: D165 year: 2022 ident: 1961_CR32 publication-title: Nucleic Acids Res. doi: 10.1093/nar/gkab1113 – volume: 571 start-page: 270 year: 2019 ident: 1961_CR8 publication-title: Nature doi: 10.1038/s41586-019-1324-y – volume: 20 start-page: 1335 year: 2019 ident: 1961_CR42 publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0480-4 – volume: 51 start-page: 840 year: 2019 ident: 1961_CR29 publication-title: Immunity doi: 10.1016/j.immuni.2019.09.013
SSID	ssj0014764
Score	2.540044
Snippet	PD-1 is a key negative regulator of CD8 + T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1... PD-1 is a key negative regulator of CD8 T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1... PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1... PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. While PD-1...
SourceID	pubmedcentral proquest pubmed crossref springer
SourceType	Open Access Repository Aggregation Database Index Database Enrichment Source Publisher
StartPage	1871
SubjectTerms	631/250/1619/554/1834 631/250/2502/2170 631/250/255/2514 631/337/100/102 Animals Biomedical and Life Sciences Biomedicine CD8 antigen CD8-Positive T-Lymphocytes - immunology Cell activation Chronic infection Clonal deletion Enhancer Elements, Genetic - genetics Epigenesis, Genetic Epigenetics Immunological memory Immunology Infections Infectious Diseases Lymphocyte Activation - immunology Lymphocytes Lymphocytes T Lymphocytic Choriomeningitis - immunology Lymphocytic Choriomeningitis - virology Memory cells Mice Mice, Inbred C57BL Mice, Knockout PD-1 protein Programmed Cell Death 1 Receptor - genetics Programmed Cell Death 1 Receptor - metabolism Viral infections
Title	Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control
URI	https://link.springer.com/article/10.1038/s41590-024-01961-3 https://www.ncbi.nlm.nih.gov/pubmed/39289557 https://www.proquest.com/docview/3110556545 https://www.proquest.com/docview/3106459725 https://pubmed.ncbi.nlm.nih.gov/PMC11528687
Volume	25
WOSCitedRecordID	wos001314855400003&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVPQU databaseName: AUTh Library subscriptions: ProQuest Central customDbUrl: eissn: 1529-2916 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: BENPR dateStart: 20230101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1529-2916 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: M7P dateStart: 20230101 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Proquest Health and Medical Complete customDbUrl: eissn: 1529-2916 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: 7X7 dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1529-2916 dateEnd: 20241207 omitProxy: false ssIdentifier: ssj0014764 issn: 1529-2908 databaseCode: 8C1 dateStart: 20230101 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwELfYBogXPgaMwqiMxBtYS2LHdp4QjE48QFWhgcpTFH9plaa0rO0E_z13jpupTOwFRfJDbCux75y7-H7-HSGvpeK-DJljRqrARGU00w38rGgw79ZyK7IIkP3-WY3HejqtJmnDbZlglZtvYvxQu7nFPfIjnsdUjmDw3y1-MswahdHVlEJjh-whSwKP0L1JH0UQKtJHgYmqWFFlOh2aybg-WoLhqjIGFoohQ0zO-LZhuuZtXgdN_hU5jQbp5MH_DuUhuZ9cUfq-051H5JZv98mdLjnl731y90sKuz8mP0YLJO3E8450tcadFDoPdPKR5dT_Skjals7i_oRfwr0zZBPyjp5SDAxQNJ6oALRpHUVU8TlNEPkn5NvJ6PT4E0s5GZgFV2PFbNYEBQuZw2UcTHDJheW6CYVDKCD4RypYmVtwZILLnQjKOSWkseCoeWE4f0p223nrnxFqVO5lyITn1ogmlMaWjRTKGBlyKW0YkHwjkNomwnLMm3Fex8A513UnxBqEWEch1nxA3vR9Fh1dx42tDzcCqtPSXdZX0hmQV301LDqcsKb18zW2QZq_ShXQ5qBTi_5x4HDqqizVgOgthekbIKH3dk07O4vE3uCdF1pq6Pp2o1tX7_XvYTy_eRgvyL0C9TwiEA_J7upi7V-S2_ZyNVteDMmOmqpYaij1cT4kex9G48nXYVxLfwA8Mx81
linkProvider	ProQuest
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9QwELaq8rzwKK-FAkaCE1hNYsd2Dggh2qpVt6s9LKicQuKHulKVXZpdoH-K38iM86iWit56QHvbOLux83m-sefzDCGvpeIu9ZFlpVSeiazUTBewWNFA78ZwI6IgkP0yVKORPjrKxmvkd3cWBmWVnU0MhtrODO6Rb_E4lHIEwv8w_86wahRGV7sSGg0sDtzZT1iy1e_3t-H9vkmS3Z3Jpz3WVhVgBshywUxUeAVQ5PAprVAy5cJwXfjEopgNGF55I2MDVOxtbIVX1iohSwOuhhMlboCCyb8GbkSig1Rw3Ect4MdCFDtNMpZkkW4P6URcb9VAlFnEgBEZZqSJGV8lwgve7UWR5l-R2kCAu3f_t6G7R-60rjb92MyN-2TNVRvkRlN882yD3DxsZQUPyNedOSYlxfOcdLHEnSI683S8zWLqfrVK4YpOw_6Lq-G7Y8yW5CydUAx8UHQOEOC0qCxF1fQJbY8APCSfr6SLj8h6NavcE0JLFTvpI-G4KUXh09KkhRSqLKWPpTR-QOIOALlpE7JjXZCTPAgDuM4b0OQAmjyAJucD8ra_Z96kI7m09WYHiLw1TXV-joYBedVfBqOCA1ZUbrbENpjGMFMJtHncwLD_O3CodZamakD0CkD7BpiwfPVKNT0Oicth9ZFoqeHWdx2Wz5_r3914enk3XpJbe5PDYT7cHx08I7cTnGNBbblJ1henS_ecXDc_FtP69EWYrZR8u2qM_wFP5HZt
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V3Pb9MwFLamAROXAeNXYYCR4ARWk9ixnQNCaF3FtFH1MNA4ZbFja5WmtFtaYP8afx3vOUmnMrHbDqi3xmlj5_P7nu3vvUfIG6m4S31UMiOVZyIzmukCFisa6N1abkUUBLLfDtRopI-OsvEa-d3FwqCssrOJwVCXU4t75H0eh1KOQPh938oixoPhx9kZwwpSeNLaldNoILLvLn7C8q3-sDeAd_02SYa7hzufWVthgFkgzjmzUeEVwJLDx5RCyZQLy3XhkxKFbcD2ylsZW6BlX8al8KoslZDGgtvhhMHNUDD_txQHFGOU-s5SXhLDj4UT7TTJWJJFug3Yibju10CaWcSAHRlmp4kZXyXFK57uVcHmX6e2gQyH9_7nYbxPNlsXnH5q5swDsuaqLXKnKcp5sUU2vrRyg4fk--4Mk5VinCedL3AHiU49HQ9YTN2vVkFc0UnYl3E1fHeCWZRcSQ8pHohQdBoQ-LSoSopq6lPahgY8Il9vpIuPyXo1rdxTQo2KnfSRcNwaUfjU2LSQQhkjfSyl9T0Sd2DIbZuoHeuFnOZBMMB13gAoBwDlAUA575F3y3tmTZqSa1tvd-DIW5NV55fI6JHXy8tgbHDAispNF9gG0xtmKoE2TxpILv8OHG2dpanqEb0C1mUDTGS-eqWanISE5rAqSbTUcOv7DteXz_Xvbjy7vhuvyAZAOz_YG-0_J3cTnG5BhLlN1ufnC_eC3LY_5pP6_GWYuJQc3zTE_wDQC37j
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Epigenetic+tuning+of+PD-1+expression+improves+exhausted+T+cell+function+and+viral+control&rft.jtitle=Nature+immunology&rft.au=Weiss%2C+Sarah+A.&rft.au=Huang%2C+Amy+Y.&rft.au=Fung%2C+Megan+E.&rft.au=Martinez%2C+Daniela&rft.date=2024-10-01&rft.issn=1529-2908&rft.eissn=1529-2916&rft.volume=25&rft.issue=10&rft.spage=1871&rft.epage=1883&rft_id=info:doi/10.1038%2Fs41590-024-01961-3&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_s41590_024_01961_3
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1529-2908&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1529-2908&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1529-2908&client=summon